Miltenyi Biotec
Miltenyi Biotec home - back to start page
Home ¦ Contact ¦ Ordering ¦ Terms & conditions ¦ Legal notes ¦ Jobs ¦ Forum ¦ Business development ¦ Sitemap
Miltenyi Biotec home - back to start page
Miltenyi Biotec home - back to start page
Miltenyi Biotec
MACS® Cell SeparationMiltenyi BiotecMACS® Cell AnalysisMiltenyi BiotecMACS® Cell CultureMiltenyi BiotecMACSmolecularMiltenyi BiotecClinical ProductsMiltenyi BiotecIndustrial ServicesMiltenyi BiotecMiltenyi BiotecCustomer supportMiltenyi BiotecCompany

Miltenyi Biotec
MACS® Tools for neuroscience research
Tregs—the complete portfolio
Comprehensive Genomics Services, just send your samples…
Baxter products
MACS Cytokines and Growth Factors
MACS eNewsletter
Subscribe to the
MACS eNewsletter
for regular product information via e-mail.
Miltenyi Biotec
CD4+CD25+ Regulatory T Cell Isolation Kit
Description
The CD4+CD25+ Regulatory T Cell Isolation Kit was developed for the isolation of CD4+CD25+ cells from PBMCs. The kit contains a cocktail of biotinylated antibodies and Anti-Biotin MicroBeads for depletion of non-CD4+ T cells, and CD25 MicroBeads for subsequent positive selection of the CD4+CD25+ cells. The kit also includes CD25-PE for quality control of the separations.
CD4+CD25+ T cells act as regulatory T cells upon activation through their T cell receptor. CD4+CD25+ regulatory T cells were originally discovered in mice, but a population with similar phenotypic and functional properties has also been characterized in humans. Regulatory CD4+CD25+ T cells seem to suppress harmful immunological reactions to self or foreign antigens.
Applications
The CD4+CD25+ Regulatory T Cell Isolation Kit has been used to investigate the role of CD4+CD25+ regulatory T cells in autoimmune diseases1,2, antitumor immunity3-5, allergy6, and in infectious diseases7. For further characterization, CD4+CD25+ regulatory T cells were isolated from patients suffering from rheumatoid arthritis1 or multiple sclerosis2, from acute T cell lymphoma patients4, from tumor biopsy specimens of non-Hodgkin lymphoma patients5 as well as from patients with atopic dermatitis6.
Columns
For depletion of non-CD4+ T cells: LD or autoMACS™ Columns. For positive selection of CD25+ cells: MS or autoMACS Columns.
 
Figure 1
Isolation of human peripheral blood CD4+CD25+ regulatory T cells using the CD4+CD25+ Regulatory T Cell Isolation Kit.
Pre-enriched CD4+ T cells after depletion of non-CD4+ cells
CD4+CD25+ T cells
Figure 2
Analysis of Foxp3 expression by CD4+CD25+ regulatory T cells, gated on CD4+ cells
Before separation
After separation
Figure 3
Analysis of CD127 expression by CD4+CD25+ regulatory T cells, gated on CD4+ cells.
Before separation
After separation
Miltenyi Biotec
Customer login
Customer login
Forgot your password?
New customer?
Get more information
My favorites
Your current favorite list is empty.
Products
CD4+CD25+ Regulatory T Cell Isolation Kit, human
for 109 total cells
Download data sheet
130-091-301
Qty:
 

Related products
CD4 Antibodies
MACS® Cell Analysis Reagents
T Cell Activation/Expansion Kit, human (#130-091-441)
Anti-FoxP3 Antibodies
CD4+CD25+CD127dim/- Regulatory T Cell Isolation Kit
Treg Suppression Inspector, human (#130-092-909)
MACS References
1. Ehrenstein et al. (2004) J. Exp. Med. 200: 277-285.[4294]
2. Hong et al. (2006) Proc. Natl. Acad. Sci. USA 103: 5024-5029.[8521]
3. Nishikawa et al. (2006) J. Immunol. 176: 6340-6346.[8684]
4. Karube et al. (2004) Br. J. Haematol. 126: 81-84.[4295]
5. Yang et al. (2006) Blood 107: 3639-3646.[8980]
6. Ou et al. (2004) J. Allergy Clin. Immunol. 113: 756-763.[6194]
7. Xu et al. (2006) J. Immunol. 177: 739-747.[8843]
Miltenyi Biotec
Miltenyi Biotec
© 1999 - 2008 Miltenyi Biotec
Miltenyi Biotec